RAC-Beta Serine/threonine-Protein Kinase (AKT2) Peptide

Este producto es parte de AKT2 - RAC-beta serine/threonine-protein kinase 2
Product Graph
175.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
RAC-Beta Serine/threonine-Protein Kinase (AKT2) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx269689
tested applications
P-ELISA

Description

RAC-Beta Serine/threonine-Protein Kinase (AKT2) Peptide is a synthetic peptide. 

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
RAC-Beta Serine/threonine-Protein Kinase (AKT2)
Host
Synthetic
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Observed MW
Sequence Fragment: C-Terminus: C-RYDSLGLLELDQRT
Size 1
100 µg
Form
Lyophilized Reconstitute in deionized water.
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
208
NCBI Accession
NP_001617.1
Alias
AKT2,PKB beta,Protein kinase Akt ,Protein kinase B beta
Background
Protein AKT2
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH15498

Human AKT2 (RAC-beta serine/threonine-protein kinase) ELISA Kit

Ver Producto
FNab00272

AKT2 antibody

AKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis and their activation has been observed in a wide variety of cancers. AKT2 is mainly involved in cancer cell survival, apoptosis inhibition, migration and invasion(PMID:21979951). The full length protein has four glycosylation sites.

Ver Producto
P0509

Recombinant Human AKT2

Ver Producto